Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|July 7, 2024
Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 TrialHirotoshi Watanabe, Masahiro Natsuaki, Takeshi Morimoto, et al.
Journal of the American College of Cardiology|October 25, 2023
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary InterventionHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
Circulation Reports|November 11, 2024
Bioprosthetic Valve Positions in Patients With Atrial Fibrillation - Insights From the BPV-AF RegistryYuki Obayashi, Makoto Miyake, Misa Takegami, et al.
Circulation. Cardiovascular Interventions|March 18, 2026
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total CohortHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 10, 2022
Comparison of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and an Aortic Bioprosthetic ValveMakoto Miyake, Misa Takegami, Yuki Obayashi, et al.
JACC. Asia|March 6, 2023
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCIKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
JACC. Cardiovascular Interventions|December 21, 2024
Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, et al.
Circulation. Cardiovascular Interventions|August 1, 2022
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total CohortYuki Obayashi, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Pageof 6